Mark brings more than 25 years of proven leadership experience with expertise in global growth, operational efficiency, integration and transformation.

He most recently served as President of Provant Health until its acquisition in 2018, and as CFO of the Clinical Effective division of Wolters Kluwer, where he provided strategic and transformative leadership that enabled the company to become the global leader in point-of-care clinical decision support.

Previously, Mark held multiple finance leadership roles at Mercer Global Investments, a division of Marsh & McLennan Companies, PFPC, Inc. (now BNY Mellon), and First Data Corporation.